Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-22 4:17 pm Purchase |
2024-10-15 | 13D | CAMP4 Therapeutics Corporation CAMP |
5AM Ventures VI L.P. | 2,927,915 15.000% |
2,927,915 (New Position) |
Filing History |
| 2024-08-01 4:17 pm Purchase |
2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV |
5AM Ventures VI L.P. | 2,353,304 10.100% |
2,353,304 (New Position) |
Filing History |
| 2024-07-29 6:12 pm Sale |
2024-07-25 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 2,304,332 4.900% |
-531,543 (-18.74%) |
Filing History |
| 2024-04-15 7:21 pm Sale |
2024-04-11 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 2,835,875 6.100% |
-1,000,100 (-26.07%) |
Filing History |
| 2024-02-16 4:15 pm Sale |
2024-02-14 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 3,835,975 9.300% |
-825,000 (-17.70%) |
Filing History |
| 2024-02-14 4:17 pm Sale |
2024-02-14 | 13D | Vor Biopharma Inc. VOR |
5AM Ventures VI L.P. | 6,361,723 9.400% |
-330,706 (-4.94%) |
Filing History |
| 2024-02-02 4:15 pm Sale |
2024-01-31 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 4,660,975 11.300% |
-700,563 (-13.07%) |
Filing History |
| 2023-08-28 4:15 pm Sale |
2023-08-24 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 5,361,538 13.000% |
-436,937 (-7.54%) |
Filing History |
| 2023-03-06 4:00 pm Purchase |
2023-02-23 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 5,798,475 14.100% |
5,798,475 (New Position) |
Filing History |
| 2023-02-28 4:30 pm Sale |
2023-02-24 | 13D | CinCor Pharma, Inc. CINC |
5AM Ventures VI L.P. | 0 0.000% |
-4,937,646 (Position Closed) |
Filing History |
| 2023-01-18 4:00 pm Purchase |
2023-01-08 | 13D | CinCor Pharma, Inc. CINC |
5AM Ventures VI L.P. | 4,937,646 11.300% |
600,000 (+13.83%) |
Filing History |
| 2022-01-21 4:15 pm Purchase |
2022-01-11 | 13G | CinCor Pharma, Inc. CINC |
5AM Ventures VI L.P. | 4,337,646 11.900% |
4,337,646 (New Position) |
Filing History |
| 2021-02-19 4:35 pm Purchase |
2021-02-09 | 13D | Vor Biopharma Inc. VOR |
5AM Ventures VI L.P. | 6,692,429 18.000% |
6,692,429 (New Position) |
Filing History |